計畫


第 1 到 25 筆結果，共 25 筆。

啟始時間標題P-Investigator經費來源
2020To Explore the Relationship between Therapeutic Outcomes of Immune Checkpoint Blockade Therapy and Gut Microbiome in Patients with Recurrent Head-And–Neck CancerRUEY-LONG HONGNational Science and Technology Council
2016Identifying Tumor-Associated Antigens and Polyfunctionality of Pd-1+ Cd8+ T Cell Responses in Patients with Head and Neck Cancer( II )RUEY-LONG HONGNational Science and Technology Council
2015Identifying Tumor-Associated Antigens and Polyfunctionality of PD-1+ CD8+T Cell Responses in Patients with Head and Neck Cancer (I)RUEY-LONG HONGNational Science and Technology Council
2010Comparison of CYFRA 21-1 with Serum DNA Integrity as a Tumor Marker for Advanced Head and Neck CancerRUEY-LONG HONGNational Science and Technology Council
2008Comparison of CYFRA 21-1 with Serum DNA Integrity as a Tumor Marker for Advanced Head and Neck CancerRUEY-LONG HONGNational Science and Technology Council
2007Establishment of Quantitative Assays of Circulating Annexin A1 and Exploring Its Correlation with AngiogenesisRUEY-LONG HONGNational Science and Technology Council
2006Establishment of Quantitative Assays of Circulating Annexin A1 and Exploring Its Correlation with AngiogenesisRUEY-LONG HONGNational Science and Technology Council
2005Quantitation of Circulating Total and EBV DNA and Outcome of Nasopharyngeal Carcinoma (NPC)RUEY-LONG HONGNational Science and Technology Council
2004Surveillance with Real Time Quantitative Polymerase Chain Reaction of Circulating Epstein-Barr Virus DNA and Positron Emission Tomography in Patients with Advanced Nasopharyngeal Carcinoma (II)RUEY-LONG HONGNational Science and Technology Council
2004癌轉移相關蛋白CD44變型的製造純化及等異抗體的生產RUEY-LONG HONGMinistry of Health and Welfare
2004Expression of Invasiveness Metastasis Related Proteins in Breast CancerRUEY-LONG HONGNational Science and Technology Council
2003CD44 Variants in Common Malignancy---A Preliminary Study for Its Implication in Cancer MetastasisRUEY-LONG HONGNational Science and Technology Council
2003Surveillance with Real Time Quantitative Polymerase Chain Reaction of Circulating Epstein-Barr Virus DNA and Positron Emission Tomography in Patients with Advanced Nasopharyngeal Carcinoma (I)RUEY-LONG HONGNational Science and Technology Council
2002Angiogenesis-Targeting Liposome for Cancer TherapyRUEY-LONG HONGNational Science and Technology Council
2001Penetrating Peptides to Facilitate Intracellular Delivery of Liposomes for Cancer TherapyRUEY-LONG HONGNational Science and Technology Council
2000Comparison of Tumor Markers of NPC-Evaluating Quantitative Analysis of Plasma EBV with Real Time Quantitative PCRRUEY-LONG HONGNational Science and Technology Council
1999Prevention and Therapy of Intraperitoneal Cancer Recurrence with Liposomal Doxorubicin and PharmacokineticsRUEY-LONG HONGNational Science and Technology Council
1999Studies on Treatment and Biology of Common Cancers in TaiwanRUEY-LONG HONGMinistry of Health and Welfare
1999Comparison of CYFRA 21-1 with Serum Dna Integrity as a Tumor Marker for Advanced Head and Neck CancerRUEY-LONG HONGNational Science and Technology Council
1998Activation of Stress Activated Protein Kinase and Drug ResistanceRUEY-LONG HONGNational Science and Technology Council
1998Treatment of Human Breast Cancer with Sterically Stabilized Liposomal Curcumin, a Tyrosine Kinase Inhibitor, in a Xenogeneic Tumor ModelRUEY-LONG HONGNational Science and Technology Council
1997An Animal Model Study of Concurrent Chemoradiotherapy with Liposomal DoxorubicinRUEY-LONG HONGNational Science and Technology Council
1997Treatment of Human Breast Cancer with Sterically Stablized Liposomal Curcumin, a Tyrosine Kinase Inhibitor, in a Xenogeneic Tumor Model (II)RUEY-LONG HONGNational Science and Technology Council
1996The Significance of HER-2/neu Oncogene in Breast CarcinogenesisRUEY-LONG HONGNational Science and Technology Council
1995Generation of Antibody Against Focal Adhesion Kinase and Study of Its Expression in Tumor Tissues and Cell LinesRUEY-LONG HONGNational Science and Technology Council